583 related articles for article (PubMed ID: 15001455)
1. Dysfunction of endothelial nitric oxide synthase and atherosclerosis.
Kawashima S; Yokoyama M
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):998-1005. PubMed ID: 15001455
[TBL] [Abstract][Full Text] [Related]
2. The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis.
Kawashima S
Endothelium; 2004; 11(2):99-107. PubMed ID: 15370069
[TBL] [Abstract][Full Text] [Related]
3. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
[TBL] [Abstract][Full Text] [Related]
4. Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis.
Kawashima S
J Pharmacol Sci; 2004 Dec; 96(4):411-9. PubMed ID: 15613778
[TBL] [Abstract][Full Text] [Related]
5. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.
Cai S; Khoo J; Channon KM
Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
7. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression.
Takaya T; Hirata K; Yamashita T; Shinohara M; Sasaki N; Inoue N; Yada T; Goto M; Fukatsu A; Hayashi T; Alp NJ; Channon KM; Yokoyama M; Kawashima S
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1632-7. PubMed ID: 17463333
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.
Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M
J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
Schmidt TS; Alp NJ
Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice.
Luo JD; Wang YY; Fu WL; Wu J; Chen AF
Circulation; 2004 Oct; 110(16):2484-93. PubMed ID: 15262829
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
Channon KM
Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell superoxide anion radical generation is not dependent on endothelial nitric oxide synthase-serine 1179 phosphorylation and endothelial nitric oxide synthase dimer/monomer distribution.
Whitsett J; Martásek P; Zhao H; Schauer DW; Hatakeyama K; Kalyanaraman B; Vásquez-Vivar J
Free Radic Biol Med; 2006 Jun; 40(11):2056-68. PubMed ID: 16716906
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors.
Channon KM; Guzik TJ
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):515-24. PubMed ID: 12512689
[TBL] [Abstract][Full Text] [Related]
14. Integrin-linked kinase regulates vasomotor function by preventing endothelial nitric oxide synthase uncoupling: role in atherosclerosis.
Herranz B; Marquez S; Guijarro B; Aracil E; Aicart-Ramos C; Rodriguez-Crespo I; Serrano I; Rodríguez-Puyol M; Zaragoza C; Saura M
Circ Res; 2012 Feb; 110(3):439-49. PubMed ID: 22194624
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus.
Sasaki N; Yamashita T; Takaya T; Shinohara M; Shiraki R; Takeda M; Emoto N; Fukatsu A; Hayashi T; Ikemoto K; Nomura T; Yokoyama M; Hirata K; Kawashima S
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1068-76. PubMed ID: 18403727
[TBL] [Abstract][Full Text] [Related]
16. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
Alp NJ; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):413-20. PubMed ID: 14656731
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase.
Wever RM; van Dam T; van Rijn HJ; de Groot F; Rabelink TJ
Biochem Biophys Res Commun; 1997 Aug; 237(2):340-4. PubMed ID: 9268712
[TBL] [Abstract][Full Text] [Related]
19. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin and endothelial function.
Cosentino F; Lüscher TF
Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
